Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

2018 Global Flow Cytometry Market: Analyzer & Reagents - Supplier Shares & Sales Segment Forecasts by Test & Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities - ResearchAndMarkets.com

Research and Markets
Posted on: 27 Nov 18

The "2018 Global Flow Cytometry Market: US, Europe, Japan - Analyzer and Reagents - Supplier Shares and Sales Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities" report has been added to ResearchAndMarkets.com's offering.

This 7-country report will help current suppliers and potential market entrants identify and evaluate emerging opportunities in the flow cytometry markets during the next five years.

The report explores future marketing and technological trends in seven countries; provides market share estimates, test volume forecasts, and instrument placements; compares features of major clinical and research flow cytometers; profiles competitors and emerging market entrants; and suggests specific product and marketing opportunities for flow cytometry instruments and reagents.

Rationale

During the next five years, continued advances in molecular diagnostics, monoclonal antibodies, lasers and IT, as well as growing understanding of immunologic forces regulating systemic diseases, will have a profound impact on the flow cytometry markets worldwide.

New molecular diagnostic and monoclonal antibody tests will facilitate existing procedures and provide basis for sensitive, specific and simple assays. The introduction of smaller and easy-to-operate laser systems will further expand applications of flow cytometry to routine clinical laboratories.

Further advances in IT will reduce the cost of instrument manufacture, service warranty, and permit development of self-troubleshooting, autocalibration and other advanced features. Presently tedious analyses of chromosomal abnormalities, DNA content, and lymphocyte subsets will become more automated and routine.

Companies Featured

  • Abbott
  • Agilent Technologies
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Bio-Rad
  • CellaVision
  • Horiba
  • Iris Diagnostics/Danaher
  • Nihon Kohden
  • Ortho-Clinical Diagnostics
  • Roche
  • Siemens
  • Sysmex

For more information about this report visit https://www.researchandmarkets.com/research/v8z6fs/2018_global_flow?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20181127005588/en/

Business Wire
www.businesswire.com

Last updated on: 27/11/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.